Metabolic diseases, including obesity, type 2 diabetes, nonalcoholic fatty liver disease and cardiovascular disease, have caused great harm to human health, and have become important public health issues threatening the lives and well-being of the Chinese population.

This session, which will be held by the Metabolic Biology Academic Subgroup of the Biophysical Society of China and undertaken by the Second Xiangya Hospital of Central South University in Hunan province, aims to promote further academic exchanges, cooperation and development of metabolic research in China. The topics of the session will include: pathogenesis and interventions of obesity and related diseases such as type 2 diabetes, complications of diabetes and non-alcoholic fatty liver disease, the regulation and mechanisms of immunity, nutrition and gut microbiota in maintaining energy homeostasis, network regulation of metabolic homeostasis and the discovery and identification of new targets and mechanisms, as well as the exploration of new targets in metabolic research, novel cytokines and hormones, new regulatory mechanisms, and the establishment of new methods and technologies.

The session will invite well-known experts to explore major scientific and clinical issues in metabolism research from basic to clinical perspectives and share innovative and leading research achievements in recent years in glucose and lipid metabolism disorders, energy imbalance and organ damage.

Chairs

Li Wei

Professor, Beijing Children's Hospital 

Zhong Qing

Professor, Shanghai Jiao Tong University School of Medicine 

Invited speakers & reports

Chang Yongsheng

Professor, Tianjin Medical University

Report: Foxi2 and energy metabolism

Zheng Hongting

Chief physician & professor, Xinqiao Hospital of Army Medical University

Report: Lipid metabolism disorders and diabetic cardiomyopathy

Wang Yiguo

Professor, Tsinghua University

Report: Hormone regulation of metabolism

Li Yu

Research fellow, Shanghai Institute of Nutrition and Health, CAS

Report: Nutrient sensing and molecular control of metabolism in the liver

Liu Pingsheng

Institute of Biophysics, CAS 

Report: 17bHSD family proteins mediate lipid droplet dynamics and fatty liver disease

Hu Cheng     

Shanghai Jiao Tong University

Report: Neuregulin 4 and metabolic regulation

Yang Jichun  

Peking University

Report: Novel hepatic factor FAM3D and glycolipid metabolism regulation

Ye Jianping   

Zhengzhou University

Report: Type 2 diabetes is a protective mechanism in compensation for burden of energy surplus